University of Texas Southwestern Medical Center Rheumatology

Topics

• Rheumatoid Arthritis Research and Therapies 393
• Systemic Lupus Erythematosus Research 161
• T-cell and B-cell Immunology 113
• Monoclonal and Polyclonal Antibodies Research 79
• Spondyloarthritis Studies and Treatments 73
• Systemic Sclerosis and Related Diseases 69
• Immune Cell Function and Interaction 55
• Biosimilars and Bioanalytical Methods 40
• Pregnancy and Medication Impact 38
• Autoimmune and Inflammatory Disorders Research 27
• Phagocytosis and Immune Regulation 27
• Parkinson's Disease Mechanisms and Treatments 26

Most cited

1. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.

   The New England journal of medicine · 2022 · 1,444 citations · Roy Fleischmann

2. 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.

   Arthritis care & research · 2026 · 48 citations · Bonnie Bermas

3. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

   Lancet (London, England) · 2021 · 476 citations · Cristina Arriens

4. 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis.

   Arthritis & rheumatology (Hoboken, N.J.) · 2025 · 101 citations · Bonnie Bermas

5. Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging.

   JACC. Cardiovascular imaging · 2024 · 127 citations · Brittany Weber

6. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis.

   RMD open · 2023 · 189 citations · Stanley Cohen